Cancer Specialists Seek Fewer Restrictions On Medicare Coverage For PET
This article was originally published in The Gray Sheet
Executive Summary
Oncologists and imaging device manufacturers are urging CMS not to restrict coverage for PET scans used to detect recurrence, monitor treatment or restage a cancer prognosis after its initial diagnosis